66 related articles for article (PubMed ID: 21882282)
1. Molecular profiling reveals frequent gain of MYCN and anaplasia-specific loss of 4q and 14q in Wilms tumor.
Williams RD; Al-Saadi R; Natrajan R; Mackay A; Chagtai T; Little S; Hing SN; Fenwick K; Ashworth A; Grundy P; Anderson JR; Dome JS; Perlman EJ; Jones C; Pritchard-Jones K
Genes Chromosomes Cancer; 2011 Dec; 50(12):982-95. PubMed ID: 21882282
[TBL] [Abstract][Full Text] [Related]
2. Bromodomain 4 inhibition leads to MYCN downregulation in Wilms tumor.
Woods AD; Berlow NE; Ortiz MV; Dela Cruz F; Siddiquee A; Coutinho DF; Purohit R; Freier KET; Michalek JE; Lathara M; Matlock K; Srivivasa G; Royer-Pokora B; Veselska R; Kung AL; Keller C
Pediatr Blood Cancer; 2022 Feb; 69(2):e29401. PubMed ID: 34693628
[TBL] [Abstract][Full Text] [Related]
3. Correlations between Histological and Array Comparative Genomic Hybridization Characterizations of Wilms Tumor.
Chiang MR; Kuo CW; Wang WC; Hou TC; Kuo CY; Lu MY; Lai YC
Pathol Oncol Res; 2019 Jul; 25(3):1199-1206. PubMed ID: 30671724
[TBL] [Abstract][Full Text] [Related]
4. A Gradual Transition Toward Anaplasia in Wilms Tumor Through Tolerance to Genetic Damage.
Uno K; Rastegar B; Jansson C; Durand G; Valind A; Chattopadhyay S; Bertolotti A; Ciceri S; Spreafico F; Collini P; Perotti D; Mengelbier LH; Gisselsson D
Mod Pathol; 2024 Jan; 37(1):100382. PubMed ID: 37951357
[TBL] [Abstract][Full Text] [Related]
5. Resolving the Pathogenesis of Anaplastic Wilms Tumors through Spatial Mapping of Cancer Cell Evolution.
Rastegar B; Andersson N; Petersson A; Karlsson J; Chattopadhyay S; Valind A; Jansson C; Durand G; Romerius P; Jirström K; Holmquist Mengelbier L; Gisselsson D
Clin Cancer Res; 2023 Jul; 29(14):2668-2677. PubMed ID: 37140929
[TBL] [Abstract][Full Text] [Related]
6. Genetic changes associated with relapse in favorable histology Wilms tumor: A Children's Oncology Group AREN03B2 study.
Gadd S; Huff V; Skol AD; Renfro LA; Fernandez CV; Mullen EA; Jones CD; Hoadley KA; Yap KL; Ramirez NC; Aris S; Phung QH; Perlman EJ
Cell Rep Med; 2022 Jun; 3(6):100644. PubMed ID: 35617957
[TBL] [Abstract][Full Text] [Related]
7. Copy Number Variations in Wilms Tumor: A Pilot Study From India.
Rahiman EA; Singh M; Bhatia P; Kakkar N; Trehan A; Bansal D
J Pediatr Hematol Oncol; 2020 Jul; 42(5):e299-e304. PubMed ID: 31851072
[TBL] [Abstract][Full Text] [Related]
8. Extrarenal Anaplastic Wilms Tumor: A Case Report With Genomic Analysis and Tumor Models.
Willis KR; Sathe AA; Xing C; Koduru P; Artunduaga M; Butler EB; Park JY; Kurmasheva RT; Houghton PJ; Chen KS; Rakheja D
J Pediatr Hematol Oncol; 2022 May; 44(4):147-154. PubMed ID: 35129140
[TBL] [Abstract][Full Text] [Related]
9. MYCN gene polymorphisms and Wilms tumor susceptibility in Chinese children.
Huang X; Zhao J; Zhu J; Chen S; Fu W; Tian X; Lou S; Ruan J; He J; Zhou H
J Clin Lab Anal; 2019 Nov; 33(9):e22988. PubMed ID: 31343784
[TBL] [Abstract][Full Text] [Related]
10. Gain of Chromosome 6p Correlates with Severe Anaplasia, Cellular Hyperchromasia, and Extraocular Spread of Retinoblastoma.
Stålhammar G; Yeung A; Mendoza P; Dubovy SR; William Harbour J; Grossniklaus HE
Ophthalmol Sci; 2022 Mar; 2(1):100089. PubMed ID: 36246172
[TBL] [Abstract][Full Text] [Related]
11. Delineating the interplay between oncogenic pathways and immunity in anaplastic Wilms tumors.
Su X; Lu X; Bazai SK; Dainese L; Verschuur A; Dumont B; Mouawad R; Xu L; Cheng W; Yan F; Irtan S; Lindner V; Paillard C; Le Bouc Y; Coulomb A; Malouf GG
Nat Commun; 2023 Nov; 14(1):7884. PubMed ID: 38036539
[TBL] [Abstract][Full Text] [Related]
12. Finding the way to Wilms tumor by comparing the primary and relapse tumor samples.
Spreafico F; Ciceri S; Perotti D
Cell Rep Med; 2022 Jun; 3(6):100667. PubMed ID: 35732150
[TBL] [Abstract][Full Text] [Related]
13. Some Attempts at Human Anaplasia by Means of Mucous Grafts from the Cheeks and Tongues of Rabbits and Oxen.
De L'aulnoit H
Buffalo Med Surg J; 1873 Jun; 12(11):431-433. PubMed ID: 36663113
[No Abstract] [Full Text] [Related]
14. Somatic mutations in DROSHA and DICER1 impair microRNA biogenesis through distinct mechanisms in Wilms tumours.
Rakheja D; Chen KS; Liu Y; Shukla AA; Schmid V; Chang TC; Khokhar S; Wickiser JE; Karandikar NJ; Malter JS; Mendell JT; Amatruda JF
Nat Commun; 2014 Sep; 2():4802. PubMed ID: 25190313
[TBL] [Abstract][Full Text] [Related]
15. Methylome analysis identifies a Wilms tumor epigenetic biomarker detectable in blood.
Charlton J; Williams RD; Weeks M; Sebire NJ; Popov S; Vujanic G; Mifsud W; Alcaide-German M; Butcher LM; Beck S; Pritchard-Jones K
Genome Biol; 2014 Aug; 15(8):434. PubMed ID: 25134821
[TBL] [Abstract][Full Text] [Related]
16. Race and Ethnic Group Enrollment and Outcomes for Wilms Tumor: Analysis of the Current Era Children's Oncology Group Study, AREN03B2.
Lovvorn HN; Renfro LA; Benedetti DJ; Kotagal M; Phelps HM; Ehrlich PF; Lo AC; Sandberg JK; Treece AL; Gow KW; Glick RD; Davidoff AM; Cost NG; Dix DB; Fernandez CV; Dome JS; Geller JI; Mullen EA
J Am Coll Surg; 2024 Apr; 238(4):733-749. PubMed ID: 38251681
[TBL] [Abstract][Full Text] [Related]
17. Hallmark discoveries in the biology of Wilms tumour.
Perotti D; Williams RD; Wegert J; Brzezinski J; Maschietto M; Ciceri S; Gisselsson D; Gadd S; Walz AL; Furtwaengler R; Drost J; Al-Saadi R; Evageliou N; Gooskens SL; Hong AL; Murphy AJ; Ortiz MV; O'Sullivan MJ; Mullen EA; van den Heuvel-Eibrink MM; Fernandez CV; Graf N; Grundy PE; Geller JI; Dome JS; Perlman EJ; Gessler M; Huff V; Pritchard-Jones K
Nat Rev Urol; 2024 Mar; 21(3):158-180. PubMed ID: 37848532
[TBL] [Abstract][Full Text] [Related]
18. Lipid Metabolic Reprogramming in Embryonal Neoplasms with MYCN Amplification.
Talapatra J; Reddy MM
Cancers (Basel); 2023 Apr; 15(7):. PubMed ID: 37046804
[TBL] [Abstract][Full Text] [Related]
19. The opportunities and challenges for nutritional intervention in childhood cancers.
Wang K; Yang T; Zhang Y; Gao X; Tao L
Front Nutr; 2023; 10():1091067. PubMed ID: 36925958
[TBL] [Abstract][Full Text] [Related]
20. The MYC oncogene - the grand orchestrator of cancer growth and immune evasion.
Dhanasekaran R; Deutzmann A; Mahauad-Fernandez WD; Hansen AS; Gouw AM; Felsher DW
Nat Rev Clin Oncol; 2022 Jan; 19(1):23-36. PubMed ID: 34508258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
